Back
Ligand Pharmaceuticals Vs. Annovis Bio Industry Stock Comparison
Sell
50
LGND
Ligand Pharmaceuticals
Last Price:
84.24
Seasonality Move:
-4%
Buy
58
ANVS
Annovis Bio
Last Price:
11.00
Seasonality Move:
-19.45%
Sell
50
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $84.37. The Score for LGND is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Annovis Bio (ANVS)
is a Buy
Is Annovis Bio a Buy, Sell or Hold?
- The current Annovis Bio [ANVS] share price is $11.10. The Score for ANVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- ANVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $84.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANVS Stock Price Chart
What is Annovis Bio's stock price today?
-
The Annovis Bio share price today is $11.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 56.79 | Buy |
| Chaikin Money Flow: | 50357 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.49 - 84.25) | Buy |
| Bollinger Bands (100): | (72.28 - 83.6) | Buy |
ANVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 68.47 | Buy |
| Chaikin Money Flow: | 13040653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.24 - 7.76) | Buy |
| Bollinger Bands (100): | (6.27 - 11.19) | Buy |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.49 | Buy |
| 20-day SMA: | 81.27 | Buy |
| 50-day SMA: | 80.93 | Buy |
| 200-day SMA: | 70.56 | Buy |
| 8-day EMA: | 82.96 | Buy |
| 20-day EMA: | 82.15 | Buy |
| 50-day EMA: | 80.82 | Buy |
| 200-day EMA: | 74.94 | Buy |
ANVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.1 | Buy |
| 20-day SMA: | 6.49 | Buy |
| 50-day SMA: | 7.12 | Buy |
| 200-day SMA: | 9.29 | Buy |
| 8-day EMA: | 7.81 | Buy |
| 20-day EMA: | 6.98 | Buy |
| 50-day EMA: | 7.39 | Buy |
| 200-day EMA: | 9.52 | Buy |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.71 per share, and an increase next year of $0.91 per share.
Annovis Bio Earnings Growth & ANVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ligand Pharmaceuticals Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Annovis Bio Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||